Tempest Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2019
Filed with the SEC on Aug 12, 2019 and accepted by EDGAR at Aug 12, 2019, 06:12 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Operating income | 3 months2019-04-01 to 2019-06-30 | −$10.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-01-01 to 2019-06-30 | −$20.8m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2019-04-01 to 2019-06-30 | −$9.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-01-01 to 2019-06-30 | −$20.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-04-01 to 2019-06-30 | −$0.74 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2019-01-01 to 2019-06-30 | −$1.51 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2019-01-01 to 2019-06-30 | −$21.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2019-01-01 to 2019-06-30 | $277.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-06-30 | $55.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-06-30 | $64.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-06-30 | $68.3m | us-gaap:Assets |
| Current liabilities | At period end2019-06-30 | $10.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-06-30 | $13.3m | us-gaap:Liabilities |
| Long-term debt | At period end2019-06-30 | $278.0k | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-06-30 | $199.0k | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2019-06-30 | $53.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-19-007932. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.